Results 241 to 250 of about 309,141 (294)
Some of the next articles are maybe not open access.
Experimental and Clinical Gastroenterology, 2023
This article presents a clinical case of a patient with colorectal cancer (CRC), who was diagnosed at the stage of a metastatic generalized process, due to a long asymptomatic course, non-specific symptoms and the difficulty of primary diagnosis. The features of management, as well as the possibilities of treating a patient with metastatic colorectal ...
M. V. Tsygankova, E. V. Tkachenko
+5 more sources
This article presents a clinical case of a patient with colorectal cancer (CRC), who was diagnosed at the stage of a metastatic generalized process, due to a long asymptomatic course, non-specific symptoms and the difficulty of primary diagnosis. The features of management, as well as the possibilities of treating a patient with metastatic colorectal ...
M. V. Tsygankova, E. V. Tkachenko
+5 more sources
Current Treatment Options in Oncology, 2001
Despite advances in screening procedures and the use of adjuvant therapy, approximately 50% of patients with colorectal cancer eventually will develop metastatic disease. Long-term disease-free survival can be achieved in 25% to 40% of selected patients who undergo resection of liver or lung metastases.
H L, Kindler, K L, Shulman
openaire +3 more sources
Despite advances in screening procedures and the use of adjuvant therapy, approximately 50% of patients with colorectal cancer eventually will develop metastatic disease. Long-term disease-free survival can be achieved in 25% to 40% of selected patients who undergo resection of liver or lung metastases.
H L, Kindler, K L, Shulman
openaire +3 more sources
Cancer Treatment Reviews, 2006
Metastatic colorectal cancer remains a public-health issue on a global scale. With development of a new generation of cytotoxic agents, survival has improved for patients with metastatic disease. How to maximize the benefit of chemotherapy with acceptable toxicity remains incompletely answered.
Piercarlo, Saletti, Franco, Cavalli
openaire +4 more sources
Metastatic colorectal cancer remains a public-health issue on a global scale. With development of a new generation of cytotoxic agents, survival has improved for patients with metastatic disease. How to maximize the benefit of chemotherapy with acceptable toxicity remains incompletely answered.
Piercarlo, Saletti, Franco, Cavalli
openaire +4 more sources
Prescrire international, 2019
Although the mainstay of treatment for metastatic colorectal cancer (mCRC) is chemotherapy, as has been the case for decades, the comprehensive management of mCRC actually requires a multimodality approach that involves care of the patient as a whole, not just their disease.
Mohamed E. Salem +6 more
openaire +3 more sources
Although the mainstay of treatment for metastatic colorectal cancer (mCRC) is chemotherapy, as has been the case for decades, the comprehensive management of mCRC actually requires a multimodality approach that involves care of the patient as a whole, not just their disease.
Mohamed E. Salem +6 more
openaire +3 more sources
METASTATIC ‘EARLY’ COLORECTAL CANCER
Australian and New Zealand Journal of Surgery, 1984If colorectal carcinomas where the primary tumours are confined to the wall are considered ‘early’, the likelihood of lymph node metastasis in these tumours is 21 % and for those that do not extend beyond the submucosa it is 13%. Because of the renewed interest in local treatment of small accessible rectal tumours and the use of colonoscopy for the ...
A M, Cuthbertson, E S, Hughes, E, Pihl
openaire +2 more sources
Oncology Times, 2013
Colon and rectal cancer continue to be a common disease. Despite the availability of an effective screening test, patients continue to present frequently with Stage 4 disease (metastatic spread). The most common sites of spread are the liver and the lungs.
Steven Mills, Michael J. Stamos
openaire +2 more sources
Colon and rectal cancer continue to be a common disease. Despite the availability of an effective screening test, patients continue to present frequently with Stage 4 disease (metastatic spread). The most common sites of spread are the liver and the lungs.
Steven Mills, Michael J. Stamos
openaire +2 more sources
Curable Metastatic Colorectal Cancer
Current Oncology Reports, 2011In the United States and Europe, colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death for men and women. In the course of their disease, many patients will present with metastasis, with the liver and lung being the most common locations.
Matthew J, Eadens, Axel, Grothey
openaire +2 more sources